Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Surapol, Issaragrisil"'
Autor:
Phatchanat Klaihmon, Parinya Samart, Yon Rojanasakul, Surapol Issaragrisil, Sudjit Luanpitpong
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-6 (2024)
Abstract Acute myeloid leukemia (AML) is an aggressive and genetically heterogeneous disease with poor clinical outcomes. Refractory AML is common, and relapse remains a major challenge, attributable to the presence of therapy-resistant leukemic stem
Externí odkaz:
https://doaj.org/article/c17f2b441f6343a88f3edb2bd2e7841b
Autor:
Sujittra Khampang, Chanchao Lorthongpanich, Chuti Laowtammathron, Phatchanat Klaihmon, Sukanya Meesa, Wichuda Suksomboon, Nittaya Jiamvoraphong, Pakpoom Kheolamai, Sudjit Luanpitpong, Charles A. Easley, Eisa Mahyari, Surapol Issaragrisil
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract YAP plays a vital role in controlling growth and differentiation in various cell lineages. Although the expression of YAP in mice testicular and spermatogenic cells suggests its role in mammalian spermatogenesis, the role of YAP in the devel
Externí odkaz:
https://doaj.org/article/923d5e1ad63b41af8fd9c050f9bc7c1b
Autor:
Nittaya Jiamvoraphong, Chanchao Lorthongpanich, Phatchanat Klaihmon, Pakpoom Kheolamai, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 78, Iss , Pp 103466- (2024)
The Rh-negative type O blood group (O Rh-) is considered a universal donor for emergency blood transfusions. Due to the constant shortage of this rare blood group, the production of blood cells from iPSCs derived from the O Rh- donor could potentiall
Externí odkaz:
https://doaj.org/article/7e8b16ae2e9e4a089dba333c9a6108ce
Autor:
Phatchanat Klaihmon, Chanchao Lorthongpanich, Pakpoom Kheolamai, Wannachai Saisaard, Surapol Issaragrisil
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Chronic myelogenous leukemia (CML) is a clonal hematologic malignancy of the myeloid lineage caused by the oncogenic BCR/ABL fusion protein that promotes CML cell proliferation and protects them against drug-induced apoptosis. In this study,
Externí odkaz:
https://doaj.org/article/3e7762c9992a488c9ff56dd679a37ade
Autor:
Sudjit Luanpitpong, Kantpitchar Tangkiettrakul, Xing Kang, Pimonwan Srisook, Jirarat Poohadsuan, Parinya Samart, Phatchanat Klaihmon, Montira Janan, Chanchao Lorthongpanich, Chuti Laowtammathron, Surapol Issaragrisil
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Hematopoiesis continues throughout life to produce all types of blood cells from hematopoietic stem cells (HSCs). Metabolic state is a known regulator of HSC self-renewal and differentiation, but whether and how metabolic sensor O-GlcNAcylation, whic
Externí odkaz:
https://doaj.org/article/d3a38db9865e4659b6c58c118429dc6f
Autor:
Parinya Samart, Gayathri Heenatigala Palliyage, Surapol Issaragrisil, Sudjit Luanpitpong, Yon Rojanasakul
Publikováno v:
Cell & Bioscience, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Background Lung cancer, the most common cause of cancer-related mortality worldwide, is predominantly associated with advanced/metastatic disease. The interaction between tumor cells and cancer-associated fibroblasts (CAFs) in tumor microenv
Externí odkaz:
https://doaj.org/article/82a40b078e6d41bebf25290dc2842424
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background Acute myeloid leukemia (AML) is a clonal malignant disorder which originates from a small number of leukemia-initiating cells or leukemic stem cells (LSCs)—the subpopulation that is also the root cause of relapsed/refractory AML
Externí odkaz:
https://doaj.org/article/80e43ab5dcf745b1bda52f1224668130
Autor:
Jirarat Poohadsuan, George A. O’Doherty, Weerapat Owattanapanich, Smith Kungwankiattichai, Yon Rojanasakul, Surapol Issaragrisil, Sudjit Luanpitpong
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-23 (2023)
Abstract Background Acute myeloid leukemia (AML) is an aggressive hematologic malignancy characterized by an accumulation of immature leukemic myeloblasts initiating from leukemic stem cells (LSCs)—the subpopulation that is also considered the root
Externí odkaz:
https://doaj.org/article/cc661f683d5049babb9e6d7accbe4dd0
Autor:
Chuti Laowtammathron, Chanchao Lorthongpanich, Nittaya Jiamvoraphong, Pimonwan Srisook, Phatchanat Klaihmon, Pakpoom Kheolamai, Sudjit Luanpitpong, Surapol Issaragrisil
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background In vitro production of hematopoietic stem/progenitor cells (HSPCs) from human-induced pluripotent stem cells (hiPSCs) provides opportunities for fundamental research, disease modeling, and large-scale production of HLA-matched HSP
Externí odkaz:
https://doaj.org/article/12d1c1de258740d8b67336ffc35f0066
Autor:
Nattaya Damkham, Chanchao Lorthongpanich, Phatchanat Klaihmon, Usaneeporn Lueangamornnara, Pakpoom Kheolamai, Kongtana Trakarnsanga, Surapol Issaragrisil
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-17 (2022)
Key point YAP and TAZ are required for erythroid maturation and enucleation, but they are dispensable during human HSC lineage allocation to myeloid or erythroid lineages.
Externí odkaz:
https://doaj.org/article/3b5983382988410c8eaa5f17ef9c81b9